Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
America''s Children Forum on Health and Family Statistics Resource Development SAMHSA NIDA As a member of this collaboration, the National Institute on Drug Abuse (NIDA) contributes data from the, “Monitoring the Future Survey on Illicit Drugs, Alcohol and Tobacco Trends”.
American Academy of Pediatrics (AAP) Committee on Drugs Committee, Work group, Advisory group, or Task Force FDA NICHD The AAP Committee on Drugs reviews all aspects of pediatric pharmacology, including drug indications, contraindications, absorption rates, routes of administration, dosing, use precautions, and mode of action as they apply to children. The Committee also advises the Board of Directors in matters related to drug labeling, safety, and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials.
American Academy of Pediatrics (AAP) Council on Genetics Committee, Work group, Advisory group, or Task Force CDC, HRSA NICHD The AAP Council on Genetics (COG) studies and makes recommendations to the AAP Board of Directors on recent advances in genetics and provides support to chapters on state legislative issues as they relate to genetics.
American Academy of Pediatrics (AAP) Council on Injury, Violence and Poison Prevention (COIVPP) Committee, Work group, Advisory group, or Task Force ACF, HRSA, IHS NICHD The AAP Council on Injury, Violence, and Poison Prevention was formed on July 1, 2011, with the merging of the former Section and Committee on Injury, Violence, and Poison Prevention. This new leadership body addresses all facets of injury prevention policy, programs, advocacy, and education of general pediatricians, pediatric subspecialists, and families as a unified group.
American Conference for the Treatment of HIV (ACTHIV) Meeting/ Workshop CDC, FDA, HRSA OD/DPCPSI/OAR, NICHD, NIMH The American Conference for the Treatment of HIV (ACTHIV) is a state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups. In addition, this conference serves to provide guidance to less experienced HIV clinicians based on the Federal HIV Treatment Guidelines.
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice Committee, Work group, Advisory group, or Task Force CDC, FDA NICHD The National Institutes of Health (NIH) advises the American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice about research advances that can inform gynecologic clinical practice.
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks Research Initiative FDA NINDS, NCATS, NCI, NIAAA, NIDA The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
Antimicrobial Drugs Advisory Committee Committee, Work group, Advisory group, or Task Force FDA NIAID The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of infectious diseases and disorders and makes appropriate recommendations to the Food and Drug Administration (FDA) Commissioner.
Antiretroviral Pregnancy Registry Resource Development CDC NICHD This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by various pharmaceutical companies and has a committee of external experts and government staff from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). The registry provides a resource for clinicians and researchers to improve the healthcare quality and patient safety for HIV infected mothers and their infants.
Arthritis Advisory Committee Committee, Work group, Advisory group, or Task Force FDA NIAID This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the Food and Drug Administration (FDA) for drug approval.